porno izle
porno
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi
Buffstreams

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the monthly archives: June 2020

We are pleased to present below all posts archived in 'June 2020'. If you still can't find what you are looking for, try using the search box.

Newcells Biotech scales up its operations in The Biosphere in Newcastle

Newcells Biotech, a pioneering life-sciences spin-out that applies Human induced Pluripotent Stem Cells (hiPSCs) to develop assays for drug development, have consolidated their two laboratory sites into 500m2 of laboratory and co-located office space in The Biosphere, which forms part of the Newcastle Helix cluster.

Read the rest of entry »

Hayes Parsons - Insurance & Risk Management: Covid-19 Resource Hub

OBN Members Hayes Parsons are supporting the wider community by providing clear and concise information regarding the pandemic from an insurance perspective.

Read the rest of entry »

TaylorWessing Webinar - 'Return to work: key issues for the life sciences'

A webinar tackling the challenges life science businesses face when preparing for the relaxation of lockdown and the possibility of welcoming their employees back to the office. 

 

Read the rest of entry »

Nikalyte launches the NL50 bench top nanoparticle generation system for ultra-pure and monodisperse particle deposition

Oxford, UK - Nikalyte Ltd, a nanotechnology company developing equipment and applications for nanoparticle research, introduces the NL50, a first of its kind, benchtop vacuum nanoparticle system that generates ultra-pure and monodisperse nanoparticles in vacuum which are deposited straight onto the target substrate.  The NL50 circumvents many of the problems faced when using solution and powder-based nanoparticles.

Read the rest of entry »

Horton International UK, announces the appointment of scientific recruitment heavyweight, Dafydd Wright, as Managing Partner

Executive search consultancy, Horton International UK, has announced the appointment of scientific recruitment heavyweight, Dafydd Wright, as Managing Partner.

Read the rest of entry »

Leaf Expression Systems Aids Research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) with the Development of Recombinant SARS-CoV-2 N-Protein

Leaf Expression Systems (Leaf), announces that it has developed a recombinant SARS-CoV-2 N-protein (antigen) to aid research into the Novel Coronavirus (SARS-CoV-2, 2019-nCoV) pandemic

Read the rest of entry »

RSSL Webinar: Best Practices in Environmental Monitoring - Reviewing your Process for Compliance

This webinar forms part of of complimentary RSSL series following the launch of RSSL's sterility testing service and will guide you through the complexities around sterile products manufacturing, control, testing and release.

Read the rest of entry »

Arecor Presents Positive Results for the First Phase I Clinical Trial of AT247, a Novel Ultra-Rapid Acting Insulin

Arecor Presents Positive Results for the First Phase I Clinical Trial of AT247, a Novel Ultra-Rapid Acting Insulin.  AT247 delivers significantly accelerated absorption of insulin compared to best in class treatments NovoRapid® and Fiasp®

Read the rest of entry »

Cryo-EM for Drug Discovery - Unlock structure-based drug design of challenging projects

Unlock structure-based drug design of challenging projects.

For many biological targets of interest to pharma such as membrane proteins, structural information is difficult to obtain. The large size, complexity, and/or flexibility of these targets make them unsuitable for traditional structure determination techniques such as crystallography. Without structural insights to inform your drug design, you potentially miss out on discovering more effective drug candidates.

Read the rest of entry »

Arecor announces the oral presentation of the first Phase I Clinical Trial of AT247, a novel Ultra Rapid Insulin Formulation, at the American Diabetes Association 80th Scientific Sessions

Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its abstract titled ‘Phase I Study Investigating the PD, PK and Safety of AT247 in comparison with NovoRapid® and Fiasp®’, has been selected for oral presentation at the upcoming American Diabetes Association 80th Scientific Sessions - Virtual (ADA) meeting which will be held from 12-16 June 2020.  Abstract #231-OR will be available online from 14 June 2020

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.